A reversible model for periportal fibrosis and a refined alternative to bile duct ligation

Toxicology Research

Volumn 3, Issue 2, 2014, Pages 98-109

  Probert, Philip M E ^a   Ebrahimkhani, Mohammad R ^b   Oakley, Fiona ^a   Mann, Jelena ^a   Burt, Alastair D ^a   Mann, Derek A ^a   Wright, Matthew C ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; METHAPYRILENE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; INFLAMMATORY CELL; LIVER; LIVER FIBROSIS; MALE; MORTALITY; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84894205123     PISSN: 2045452X     EISSN: 20454538     Source Type: Journal    
DOI: 10.1039/c3tx50069a     Document Type: Article

References (43)

1. K. Wallace A. D. Burt M. C. Wright Liver fibrosis Biochem. J. 2008 411 1 18 (Pubitemid 351482341)
2. Y. S. Lim W. R. Kim The global impact of hepatic fibrosis and end-stage liver disease Clin. Liver Dis. 2008 12 733 746
3. V. Hernandez-Gea S. L. Friedman Pathogenesis of liver fibrosis Annu. Rev. Pathol. 2011 6 425 456
4. A. Symeonidis E. G. Trams Morphologic and functional changes in the livers of rats after ligation or excision of the common bile duct Am. J. Pathol. 1957 33 13 27
5. B. Tuchweber A. Desmouliere M. L. Bochaton-Piallat L. Rubbia-Brandt G. Gabbiani Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat Lab. Invest. 1996 74 265 278 (Pubitemid 26041028)
6. O. Tarcin M. Basaranoglu V. Tahan G. Tahan I. Sucullu N. Yilmaz G. Sood N. Snyder G. Hilman C. Celikel N. Tozun Time course of collagen peak in bile duct-ligated rats BMC Gastroenterol. 2011 11 45
7. P. Georgiev W. Jochum S. Heinrich J. H. Jang A. Nocito F. Dahm P. A. Clavien Characterization of time-related changes after experimental bile duct ligation Br. J. Surg. 2008 95 646 656
8. W. Lijinsky M. D. Reuber B. N. Blackwell Liver tumors induced in rats by oral administration of the antihistaminic methapyrilene hydrochloride Science 1980 209 817 819 (Pubitemid 10017492)
9. L. M. Brennan D. A. Creasia The effects of methapyrilene hydrochloride on hepatocarcinogenicity and pentobarbital-induced sleeping time in rats and mice Toxicol. Appl. Pharmacol. 1982 66 252 258 (Pubitemid 13223979)
10. M. E. Graichen D. A. Neptun J. G. Dent J. A. Popp T. B. Leonard Effects of methapyrilene on rat hepatic xenobiotic metabolizing enzymes and liver morphology Fundam. Appl. Toxicol. 1985 5 165 174 (Pubitemid 15164327)
11. K. L. Steinmetz C. K. Tyson E. F. Meierhenry J. W. Spalding J. C. Mirsalis Examination of genotoxicity, toxicity and morphologic alterations in hepatocytes following in vivo or in vitro exposure to methapyrilene Carcinogenesis 1988 9 959 963
12. F. C. Richardson D. M. Copple P. I. Eacho Effects of methapyrilene on DNA synthesis in mice and rats following continuous dietary exposure Carcinogenesis 1992 13 2453 2457 (Pubitemid 23022996)
13. M. L. Cunningham L. L. Pippin N. L. Anderson M. L. Wenk The hepatocarcinogen methapyrilene but not the analog pyrilamine induces sustained hepatocellular replication and protein alterations in F344 rats in a 13-week feed study Toxicol. Appl. Pharmacol. 1995 131 216 223
14. G. S. Ratra S. Cottrell C. J. Powell Effects of induction and inhibition of cytochromes P450 on the hepatotoxicity of methapyrilene Toxicol. Sci. 1998 46 185 196 (Pubitemid 29014097)
15. H. K. Hamadeh B. L. Knight A. C. Haugen S. Sieber R. P. Amin P. R. Bushel R. Stoll K. Blanchard S. Jayadev R. W. Tennant M. L. Cunningham C. A. Afshari R. S. Paules Methapyrilene toxicity: anchorage of pathologic observations to gene expression alterations Toxicol. Pathol. 2002 30 470 482
16. A. E. Mercer S. L. Regan C. M. Hirst E. E. Graham D. J. Antoine C. A. Benson D. P. Williams J. Foster J. G. Kenna B. K. Park Functional and toxicological consequences of metabolic bioactivation of methapyrilene via thiophene S-oxidation: Induction of cell defence, apoptosis and hepatic necrosis Toxicol. Appl. Pharmacol. 2009 239 297 305
17. C. C. Priestley S. Regan B. Kevin Park D. P. Williams The genotoxic potential of methapyrilene using the alkaline Comet assay in vitro and in vivo Toxicology 2011 290 249 257
18. E. E. Graham R. J. Walsh C. M. Hirst J. L. Maggs S. Martin M. J. Wild I. D. Wilson J. R. Harding J. G. Kenna R. M. Peter D. P. Williams B. K. Park Identification of the thiophene ring of methapyrilene as a novel bioactivation-dependent hepatic toxicophore J. Pharmacol. Exp. Ther. 2008 326 657 671
19. G. S. Ratra W. A. Morgan J. Mullervy C. J. Powell M. C. Wright Methapyrilene hepatotoxicity is associated with oxidative stress, mitochondrial disfunction and is prevented by the Ca2+ channel blocker verapamil Toxicology 1998 130 79 93 (Pubitemid 28488577)
20. G. S. Ratra C. J. Powell B. K. Park J. L. Maggs S. Cottrell Methapyrilene hepatotoxicity is associated with increased hepatic glutathione, the formation of glucuronide conjugates, and enterohepatic recirculation Chem.-Biol. Interact. 2000 129 279 295 (Pubitemid 32008377)
21. P. A. Hall D. A. Levison A. L. Woods C. C. Yu D. B. Kellock J. A. Watkins D. M. Barnes C. E. Gillett R. Camplejohn R. Dover et al., Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms J. Pathol. 1990 162 285 294
22. J. P. Iredale Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ J. Clin. Invest. 2007 117 539 548 (Pubitemid 46348508)
23. S. L. Friedman Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver Physiol. Rev. 2008 88 125 172
24. S. T. Magness R. Bataller L. Yang D. A. Brenner A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations Hepatology 2004 40 1151 1159 (Pubitemid 39425571)
25. G. Ramadori B. Saile Portal tract fibrogenesis in the liver, Laboratory investigation J. Tech. Methods Pathol. 2004 84 153 159 (Pubitemid 41656496)
26. L. Libbrecht D. Cassiman V. Desmet T. Roskams The correlation between portal myofibroblasts and development of intrahepatic bile ducts and arterial branches in human liver Liver 2002 22 252 258 (Pubitemid 34846364)
27. S. L. Friedman F. J. Roll J. Boyles D. M. Bissell Hepatic lipocytes: the principal collagen-producing cells of normal rat liver Proc. Natl. Acad. Sci. U. S. A. 1985 82 8681 8685 (Pubitemid 16101107)
28. T. Nouchi Y. Tanaka T. Tsukada C. Sato F. Marumo Appearance of alpha-smooth-muscle-actin-positive cells in hepatic fibrosis Liver 1991 11 100 105
29. S. S. Glaser E. Gaudio T. Miller D. Alvaro G. Alpini Cholangiocyte proliferation and liver fibrosis Expert Rev. Mol. Med. 2009 11 e7
30. J. M. Saito J. J. Maher Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant Gastroenterology 2000 118 1157 1168 (Pubitemid 30346993)
31. P. Fickert U. Stoger A. Fuchsbichler T. Moustafa H. U. Marschall A. H. Weiglein O. Tsybrovskyy H. Jaeschke K. Zatloukal H. Denk M. Trauner A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis Am. J. Pathol. 2007 171 525 536 (Pubitemid 47344685)
32. H. M. Golbar T. Izawa C. Ichikawa M. Tanaka V. Juniantito O. Sawamoto M. Kuwamura J. Yamate Slowly progressive cholangiofibrosis induced in rats by alpha-naphthylisothiocyanate (ANIT), with particular references to characteristics of macrophages and myofibroblasts Exp. Toxicol. Pathol. 2013 65 825 835
33. A. S. Gouw A. D. Clouston N. D. Theise Ductular reactions in human liver: diversity at the interface Hepatology 2011 54 1853 1863
34. T. Masaki S. Chiba H. Tatsukawa H. Noguchi T. Kakuma M. Endo M. Seike T. Watanabe H. Yoshimatsu The role of histamine H1 receptor and H2 receptor in LPS-induced liver injury FASEB J. 2005 19 1245 1252 (Pubitemid 41113721)
35. S. J. Hill J. M. Young Histamine H1-receptors in the brain of the guinea-pig and the rat: differences in ligand binding properties and regional distribution Br. J. Pharmacol. 1980 68 687 696 (Pubitemid 10110203)
36. D. J. Farrell J. E. Hines A. F. Walls et al., Intrahepatic mast cells in chronic liver diseases Hepatology 1995 22 1175 1181
37. M. Yamashiro W. Kouda N. Kono et al., Distribution of intrahepatic mast cells in various hepatobiliary disorders. An immunohistochemical study Virchows Arch. 1998 433 471 479 (Pubitemid 28522037)
38. H. Francis S. Glaser S. Demorrow E. Gaudio Y. Ueno J. Venter D. Dostal P. Onori A. Franchitto M. Marzioni S. Vaculin B. Vaculin K. Katki M. Stutes J. Savage G. Alpini Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway Am. J. Physiol.: Cell Physiol. 2008 295 C499 C513
39. M. Ouellet M. D. Percival Mechanism of acetaminophen inhibition of cyclooxygenase isoforms Arch. Biochem. Biophys. 2001 387 273 280 (Pubitemid 32980589)
40. S. N. Pentyala P. J. Vig B. S. Sekhon D. Desaiah Effect of carbon tetrachloride on inositol 1,4,5-trisphosphate dependent and independent regulation of rat brain microsomal Ca2+ flux Cell. Signalling 1994 6 561 567
41. M. R. Ebrahimkhani S. Kiani F. Oakley T. Kendall A. Shariftabrizi S. M. Tavangar L. Moezi S. Payabvash A. Karoon H. Hoseininik D. A. Mann K. P. Moore A. R. Mani A. R. Dehpour Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats Gut 2006 55 1606 1616 (Pubitemid 44629212)
42. M. R. Ebrahimkhani F. Oakley L. B. Murphy J. Mann A. Moles M. J. Perugorria E. Ellis A. F. Lakey A. D. Burt A. Douglass M. C. Wright S. A. White F. Jaffre L. Maroteaux D. A. Mann Stimulating healthy tissue regeneration by targeting the 5-HT(2)B receptor in chronic liver disease Nat. Med. 2011 17 1668 1673
43. C. J. Marek S. J. Tucker D. K. Konstantinou L. J. Elrick D. Haefner C. Sigalas G. I. Murray B. Goodwin M. C. Wright Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane×receptor)-dependent and PXR-independent mechanisms Biochem. J. 2005 387 601 608 (Pubitemid 40685693)